Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by jtmoneyon Mar 08, 2019 2:02pm
221 Views
Post# 29462518

RE:Direct Path to 100M+ Revenue & 20M+ EBITDA Business…

RE:Direct Path to 100M+ Revenue & 20M+ EBITDA Business…Thanks Craig, as always for a great detailed write up. I’m pretty much with you on your 2019 exit run rate projections. I’m looking at a little lower in rev at 110m but a higher Ebitda of 22%, which works out basically the same Ebitda projections that you have. 

Here’s the crazy thing, when Ptq started trading on its own in Jan 2018 it was 90c.
Here we are a little more then a year later with all this progress the company has made and we’re still trading at 90c, that’s insane. Can’t wait till this starts it’s next leg up.

Glta
Bullboard Posts